Professor Davina Ghersi

Adjunct Professor
Medicine, Sydney Medical School
NHMRC Clinical Trials Centre

Telephone +61 2 9562 5040
Fax +61 2 9565 1863

Website Related website

Map

Selected grants

2006

  • Evidence on the use of trastuzumab (Herceptin´┐Ż) in advanced breast cancer and as adjuvant therapy; Ghersi D, Seed M; National Breast Cancer Foundation/BLO Project.

2005

  • Systematic review of interventions for the management of locally advanced breast cancer; Wilcken N, Ghersi D; Cure Cancer Australia Foundation/Research Support.
  • Agreement for the provision of funding to enable the development of an interim clinical trials registry; Ghersi D, Simes R, Goldstein D, Nutt M; National Health and Medical Research Council (NHMRC)/Research Support.

2003

  • Australian-based cochrane collaboration activities - COLLABORATIVE Review Group with editorial base in Australia; Ghersi D, Simes R; DHA/Cochrane Collaborative Groups Funding Scheme.

2000

  • National Breast Cancer Centre: Cochrane review group; Simes R, Ghersi D; Cancer Council New South Wales/National Breast Cancer Centre Grant.
  • Systematic reviews of randomised controlled trials of chemotherapy and endocrine therapy in advanced breast cancer; Simes R, Henderson I, Brunswick C, Ghersi D; US Army Medical Research Acquisition Group/Breast Cancer Research Program Grant.
  • Provision of assessment and research related services on medical technologies and procedures for the Medical Services Advisory Committee (MSAC); Simes R, Eckermann S, Keech A, Irwig L, Ghersi D, Stockler M, Gebski V, Eckermann S, Lord S, Howard K, Salkeld G; Department of Health and Ageing (Federal)/Research Support.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Keech, A., Ghersi, D., Gebski, V., Pike, R. (2007). Introducing the report of a randomised controlled trial: the title, abstract, scientific background and rationale. In Anthony Keech, Val Gebski, Rhana Pike (Eds.), Interpreting and reporting clinical trials: a guide to the CONSORT statement and the principles of randomised controlled trials, (pp. 8-10). Sydney: AMPCo.

Journals

  • Berlin, J., Morris, S., Rockhold, F., Askie, L., Ghersi, D., Waldstreicher, J. (2014). Bumps and bridges on the road to responsible sharing of clinical trial data. Clinical Trials, 11(1), 7-12. [More Information]
  • Goodwin, A., Parker, S., Ghersi, N., Wilcken, N. (2013). Post-operative radiotherapy for ductal carcinoma in situ of the breast (Review). Cochrane Database of Systematic Reviews, 11, 1-39. [More Information]
  • Viergever, R., Ghersi, D. (2012). Information on blinding in registered records of clinical trials. Trials, 13, 210-210. [More Information]
  • Butters, D., Ghersi, D., Wilcken, N., Kirk, S., Mallon, P. (2010). Addition of drug/s to a chemotherapy regimen for metastatic breast cancer. Cochrane Database of Systematic Reviews, 11(1), CD003368. [More Information]
  • Dickersin, K., Tovey, D., Wilcken, N., Ghersi, D. (2010). The background review for the USPSTF recommendation on screening for breast cancer. Annals of Internal Medicine, 152(8), 537; author reply 538-9. [More Information]
  • Goodwin, A., Parker, S., Ghersi, D., Wilcken, N. (2009). Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000563.pub6.(3), 1-35. [More Information]
  • Goodwin, A., Parker, S., Ghersi, D., Wilcken, N. (2009). Post-operative radiotherapy for ductal carcinoma in situ of the breast - a systematic review of the randomised trials. The Breast, 18(3), 143-149. [More Information]
  • Carrick, S., Parker, S., Thornton, C., Ghersi, D., Simes, R., Wilcken, N. (2009). Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database of Systematic Reviews, (2), CD003372-1-CD003372-109. [More Information]
  • Clayton, J., Hancock, K., Parker, S., Butow, P., Walder, S., Carrick, S., Currow, D., Ghersi, D., Glare, P., Hagerty, R., Tattersall, M., et al (2008). Sustaining hope when communicating with terminally ill patients and their families: A systematic review. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 17, 641-659. [More Information]
  • Dwan, K., Altman, D., Arnaiz, J., Bloom, J., Chan, A., Cronin, E., Decullier, E., Easterbrook, P., Von Elm, E., Gamble, C., Ghersi, D., Simes, R., et al (2008). Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias. PloS One, 3(8), e3081-1-e3081-31. [More Information]
  • Parker, S., Clayton, J., Hancock, K., Walder, S., Butow, P., Carrick, S., Currow, D., Ghersi, D., Glare, P., Hagerty, R., Tattersall, M. (2007). A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/caregiver preferences for the content, style, and timing of information. Journal of Pain and Symptom Management, 34(1), 81-93. [More Information]
  • Hancock, K., Clayton, J., Parker, S., Walder, S., Butow, P., Carrick, S., Currow, D., Ghersi, D., Glare, P., Hagerty, R., Tattersall, M. (2007). Discrepant Perceptions About End-of-Life Communication: A Systematic Review. Journal of Pain and Symptom Management, 34(2), 190-200. [More Information]
  • Tierney, J., Stewart, L., Ghersi, D., Burdett, S., Sydes, M. (2007). Practical methods for incorporating summary time-to-event data into meta-analysis. Trials, 8, 16-1-16-16. [More Information]
  • Clayton, J., Hancock, K., Parker, S., Butow, P., Walder, S., Carrick, S., Currow, D., Ghersi, D., Glare, P., Hagerty, R., Olver, I., Tattersall, M. (2007). Sustaining hope when communicating with terminally ill patients and their families: a systematic review. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, DOI: 10.1002/pon.1288(DOI: 10.1002/pon.1288), 1-19. [More Information]
  • Ferguson, T., Wilcken, N., Vagg, R., Ghersi, D., Nowak, A. (2007). Taxanes for adjuvant treatment of early breast cancer. Cochrane Database of Systematic Reviews, Art. No.: CD004421(4), 1-50. [More Information]
  • Hancock, K., Clayton, J., Parker, S., Walder, S., Butow, P., Carrick, S., Currow, D., Ghersi, D., Glare, P., Hagerty, R., Tattersall, M. (2007). Truth-telling in discussing prognosis in advanced life-limiting illnesses: a systematic review. Palliative Medicine: a multiprofessional journal, 21(6), 507-517. [More Information]
  • Steinbeck, K., Baur, L., Morris, A., Ghersi, D. (2006). A proposed protocol for the development of a register of trials of weight management of childhood overweight and obesity. International Journal of Obesity, 30(1), 2-5. [More Information]
  • Jones, D., Ghersi, D., Wilcken, N. (2006). Addition of drug/s to a chemotherapy regimen for metastatic breast cancer. Cochrane Database of Systematic Reviews, 19(3), CD003368-CD003368. [More Information]
  • Askie, L., Ghersi, D., Simes, R. (2006). Prospective registration of clinical trials (editorial). Australian Journal of Physiotherapy, 52(4), 237-239.
  • Askie, L., Ghersi, D., Simes, R. (2006). Prospective registration of clinical trials [Editorial]. Australian Journal of Physiotherapy, 52(4), 237-239. [More Information]
  • Chan, A., Upshur, R., Singh, J., Ghersi, D., Chapuis, F., Altman, D. (2006). Waiving confidentiality for the greater good. British Medical Journal, 332(7549), 1086-1089. [More Information]
  • Ghersi, D., Wilcken, N., Simes, R. (2005). A systematic review of taxane-containing regimens for metastatic breast cancer. British Journal of Cancer, 93(3), 293-301. [More Information]
  • Carrick, S., Parker, S., Thornton, C., Ghersi, D., Simes, R., Wilcken, N. (2005). Single agent versus combination chemotherapy for metastatic breast cancer (Review). Cochrane Database of Systematic Reviews, 2005 (2), 1-22. [More Information]
  • Ghersi, D., Wilcken, N., Simes, R., Donoghue, E. (2005). Taxane containing regimens for metastatic breast cancer (Review). Cochrane Database of Systematic Reviews, 2005 (2), 1-119. [More Information]
  • Van Der Weyden, M., Ghersi, D. (2005). The Australian Clinical Trial Registry. Medical Journal of Australia, 183(1), 7. [More Information]
  • Lord, S., Ghersi, D., Gattellari, M., Wilcken, N., Thornton, C., Simes, J. (2004). Antitumour Antibiotic Containing Regimens For Metastatic Breast Cancer. Cochrane Database of Systematic Reviews, 4(CD003367), 1-123.
  • Carrick, S., Ghersi, D., Wilcken, N., Simes, R. (2004). Platinum Containing Regimens For Metastatic Breast Cancer. Cochrane Database of Systematic Reviews, 2(CD003374), 1-74.
  • Berlin, J., Ghersi, D. (2004). Prospective Meta-Analysis In Dentistry. Journal of Evidence-Based Dental Practice, 4(1), 59-64. [More Information]
  • Nowak, A., Wilcken, N., Stockler, M., Hamilton, A., Ghersi, D. (2004). Systematic Review Of Taxane-Containing Versus Non-Taxane-Containing Regimens For Adjuvant And Neoadjuvant Treatment Of Early Breast Cancer. Lancet Oncology, 5(6), 372-380.
  • Ghersi, D., Wilcken, N., Simes, R., Donoghue, E. (2003). Taxane containing regimes for metastatic breast cancer. Cochrane Database of Systematic Reviews, 168(37), 3117-3120. [More Information]
  • Ghersi, D. (2002). Making it happen: approaches to involving consumers in Cochrane reviews. Evaluation and the Health Professions, 25(3), 270-283.
  • Ghersi, D., Simes, R., Stockler, M., Tattersall, M., Wilcken, N., Henderson, I., Basser, R., Brunswick, C., Fossati, C., Liberati, A., et al (2001). Addition of drug/s to a chemotherapy regimen for metastatic breast cancer [protocol]. Cochrane Database of Systematic Reviews, Issue 4, 1-4.
  • Ghersi, D., Simes, R., Stockler, M., Tattersall, M., Wilcken, N., Basser, R., Henderson, I., Brunswick, C., Fossati, R., Liberati, A., et al (2001). Antitumor antibiotic containing regimins for metastatic breast cancer [protocol]. Cochrane Database of Systematic Reviews, Issue 4, 1-4.
  • Ghersi, D., Simes, R., Stockler, M., Tattersall, M., Wilcken, N., Henderson, I., Basser, R., Brunswick, C., Fossati, R., Liberati, A., et al (2001). Larger vs smaller dose of the same drug/s regimen for metastatic breast cancer [protocol]. Cochrane Database of Systematic Reviews, Issue 4, 1-4.
  • Ghersi, D., Simes, R., Stockler, M., Tattersall, M., Wilcken, N., Henderson, I., Basser, R., Brunswick, C., Fossati, R., Liberati, A., et al (2001). Platinum containing reimens for metastatic breast cancer [protocol]. Cochrane Database of Systematic Reviews, Issue 4, 1-4.
  • Ghersi, D., Gebski, V., Keech, A. (2001). Scientific background and rationale for a randomised controlled trial. Medical Journal of Australia, 175(7), 386-386.
  • Ghersi, D., Simes, R., Stockler, M., Tattersall, M., Wilcken, N., Henderson, I., Basser, R., Brunswick, C., Fossati, R., Liberati, A., et al (2001). Single agent vs combination chemotherapy for metastatic breast cancer [protocol]. Cochrane Database of Systematic Reviews, Issue 4, 1-4.
  • Ghersi, D., Simes, R., Stockler, M., Tattersall, M., Wilcken, N., Henderson, I., Basser, R., Brunswick, C., Fossati, C., Liberati, A., et al (2001). Taxane containing regimens for metastatsic breast cancer [protocol]. Cochrane Database of Systematic Reviews, Issue 4, 1-4.
  • Ghersi, D., Simes, R., Stockler, M., Tattersall, M., Wilcken, N., Henderson, I., Basser, R., Brunswick, C., Fossati, R., Liberati, A., et al (2001). Two drug combinations vs combinations of 3 or more cytotoxic drugs for meastatic brest cancer [protocol]. Cochrane Database of Systematic Reviews, Issue 4, 1-4.
  • Stockler, M., Wilcken, N., Ghersi, D., Simes, R. (2000). Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. Cancer Treatment Reviews, 26(3), 151-168.

2014

  • Berlin, J., Morris, S., Rockhold, F., Askie, L., Ghersi, D., Waldstreicher, J. (2014). Bumps and bridges on the road to responsible sharing of clinical trial data. Clinical Trials, 11(1), 7-12. [More Information]

2013

  • Goodwin, A., Parker, S., Ghersi, N., Wilcken, N. (2013). Post-operative radiotherapy for ductal carcinoma in situ of the breast (Review). Cochrane Database of Systematic Reviews, 11, 1-39. [More Information]

2012

  • Viergever, R., Ghersi, D. (2012). Information on blinding in registered records of clinical trials. Trials, 13, 210-210. [More Information]

2010

  • Butters, D., Ghersi, D., Wilcken, N., Kirk, S., Mallon, P. (2010). Addition of drug/s to a chemotherapy regimen for metastatic breast cancer. Cochrane Database of Systematic Reviews, 11(1), CD003368. [More Information]
  • Dickersin, K., Tovey, D., Wilcken, N., Ghersi, D. (2010). The background review for the USPSTF recommendation on screening for breast cancer. Annals of Internal Medicine, 152(8), 537; author reply 538-9. [More Information]

2009

  • Goodwin, A., Parker, S., Ghersi, D., Wilcken, N. (2009). Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000563.pub6.(3), 1-35. [More Information]
  • Goodwin, A., Parker, S., Ghersi, D., Wilcken, N. (2009). Post-operative radiotherapy for ductal carcinoma in situ of the breast - a systematic review of the randomised trials. The Breast, 18(3), 143-149. [More Information]
  • Carrick, S., Parker, S., Thornton, C., Ghersi, D., Simes, R., Wilcken, N. (2009). Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database of Systematic Reviews, (2), CD003372-1-CD003372-109. [More Information]

2008

  • Clayton, J., Hancock, K., Parker, S., Butow, P., Walder, S., Carrick, S., Currow, D., Ghersi, D., Glare, P., Hagerty, R., Tattersall, M., et al (2008). Sustaining hope when communicating with terminally ill patients and their families: A systematic review. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 17, 641-659. [More Information]
  • Dwan, K., Altman, D., Arnaiz, J., Bloom, J., Chan, A., Cronin, E., Decullier, E., Easterbrook, P., Von Elm, E., Gamble, C., Ghersi, D., Simes, R., et al (2008). Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias. PloS One, 3(8), e3081-1-e3081-31. [More Information]

2007

  • Parker, S., Clayton, J., Hancock, K., Walder, S., Butow, P., Carrick, S., Currow, D., Ghersi, D., Glare, P., Hagerty, R., Tattersall, M. (2007). A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/caregiver preferences for the content, style, and timing of information. Journal of Pain and Symptom Management, 34(1), 81-93. [More Information]
  • Hancock, K., Clayton, J., Parker, S., Walder, S., Butow, P., Carrick, S., Currow, D., Ghersi, D., Glare, P., Hagerty, R., Tattersall, M. (2007). Discrepant Perceptions About End-of-Life Communication: A Systematic Review. Journal of Pain and Symptom Management, 34(2), 190-200. [More Information]
  • Keech, A., Ghersi, D., Gebski, V., Pike, R. (2007). Introducing the report of a randomised controlled trial: the title, abstract, scientific background and rationale. In Anthony Keech, Val Gebski, Rhana Pike (Eds.), Interpreting and reporting clinical trials: a guide to the CONSORT statement and the principles of randomised controlled trials, (pp. 8-10). Sydney: AMPCo.
  • Tierney, J., Stewart, L., Ghersi, D., Burdett, S., Sydes, M. (2007). Practical methods for incorporating summary time-to-event data into meta-analysis. Trials, 8, 16-1-16-16. [More Information]
  • Clayton, J., Hancock, K., Parker, S., Butow, P., Walder, S., Carrick, S., Currow, D., Ghersi, D., Glare, P., Hagerty, R., Olver, I., Tattersall, M. (2007). Sustaining hope when communicating with terminally ill patients and their families: a systematic review. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, DOI: 10.1002/pon.1288(DOI: 10.1002/pon.1288), 1-19. [More Information]
  • Ferguson, T., Wilcken, N., Vagg, R., Ghersi, D., Nowak, A. (2007). Taxanes for adjuvant treatment of early breast cancer. Cochrane Database of Systematic Reviews, Art. No.: CD004421(4), 1-50. [More Information]
  • Hancock, K., Clayton, J., Parker, S., Walder, S., Butow, P., Carrick, S., Currow, D., Ghersi, D., Glare, P., Hagerty, R., Tattersall, M. (2007). Truth-telling in discussing prognosis in advanced life-limiting illnesses: a systematic review. Palliative Medicine: a multiprofessional journal, 21(6), 507-517. [More Information]

2006

  • Steinbeck, K., Baur, L., Morris, A., Ghersi, D. (2006). A proposed protocol for the development of a register of trials of weight management of childhood overweight and obesity. International Journal of Obesity, 30(1), 2-5. [More Information]
  • Jones, D., Ghersi, D., Wilcken, N. (2006). Addition of drug/s to a chemotherapy regimen for metastatic breast cancer. Cochrane Database of Systematic Reviews, 19(3), CD003368-CD003368. [More Information]
  • Askie, L., Ghersi, D., Simes, R. (2006). Prospective registration of clinical trials (editorial). Australian Journal of Physiotherapy, 52(4), 237-239.
  • Askie, L., Ghersi, D., Simes, R. (2006). Prospective registration of clinical trials [Editorial]. Australian Journal of Physiotherapy, 52(4), 237-239. [More Information]
  • Chan, A., Upshur, R., Singh, J., Ghersi, D., Chapuis, F., Altman, D. (2006). Waiving confidentiality for the greater good. British Medical Journal, 332(7549), 1086-1089. [More Information]

2005

  • Ghersi, D., Wilcken, N., Simes, R. (2005). A systematic review of taxane-containing regimens for metastatic breast cancer. British Journal of Cancer, 93(3), 293-301. [More Information]
  • Carrick, S., Parker, S., Thornton, C., Ghersi, D., Simes, R., Wilcken, N. (2005). Single agent versus combination chemotherapy for metastatic breast cancer (Review). Cochrane Database of Systematic Reviews, 2005 (2), 1-22. [More Information]
  • Ghersi, D., Wilcken, N., Simes, R., Donoghue, E. (2005). Taxane containing regimens for metastatic breast cancer (Review). Cochrane Database of Systematic Reviews, 2005 (2), 1-119. [More Information]
  • Van Der Weyden, M., Ghersi, D. (2005). The Australian Clinical Trial Registry. Medical Journal of Australia, 183(1), 7. [More Information]

2004

  • Lord, S., Ghersi, D., Gattellari, M., Wilcken, N., Thornton, C., Simes, J. (2004). Antitumour Antibiotic Containing Regimens For Metastatic Breast Cancer. Cochrane Database of Systematic Reviews, 4(CD003367), 1-123.
  • Carrick, S., Ghersi, D., Wilcken, N., Simes, R. (2004). Platinum Containing Regimens For Metastatic Breast Cancer. Cochrane Database of Systematic Reviews, 2(CD003374), 1-74.
  • Berlin, J., Ghersi, D. (2004). Prospective Meta-Analysis In Dentistry. Journal of Evidence-Based Dental Practice, 4(1), 59-64. [More Information]
  • Nowak, A., Wilcken, N., Stockler, M., Hamilton, A., Ghersi, D. (2004). Systematic Review Of Taxane-Containing Versus Non-Taxane-Containing Regimens For Adjuvant And Neoadjuvant Treatment Of Early Breast Cancer. Lancet Oncology, 5(6), 372-380.

2003

  • Ghersi, D., Wilcken, N., Simes, R., Donoghue, E. (2003). Taxane containing regimes for metastatic breast cancer. Cochrane Database of Systematic Reviews, 168(37), 3117-3120. [More Information]

2002

  • Ghersi, D. (2002). Making it happen: approaches to involving consumers in Cochrane reviews. Evaluation and the Health Professions, 25(3), 270-283.

2001

  • Ghersi, D., Simes, R., Stockler, M., Tattersall, M., Wilcken, N., Henderson, I., Basser, R., Brunswick, C., Fossati, C., Liberati, A., et al (2001). Addition of drug/s to a chemotherapy regimen for metastatic breast cancer [protocol]. Cochrane Database of Systematic Reviews, Issue 4, 1-4.
  • Ghersi, D., Simes, R., Stockler, M., Tattersall, M., Wilcken, N., Basser, R., Henderson, I., Brunswick, C., Fossati, R., Liberati, A., et al (2001). Antitumor antibiotic containing regimins for metastatic breast cancer [protocol]. Cochrane Database of Systematic Reviews, Issue 4, 1-4.
  • Ghersi, D., Simes, R., Stockler, M., Tattersall, M., Wilcken, N., Henderson, I., Basser, R., Brunswick, C., Fossati, R., Liberati, A., et al (2001). Larger vs smaller dose of the same drug/s regimen for metastatic breast cancer [protocol]. Cochrane Database of Systematic Reviews, Issue 4, 1-4.
  • Ghersi, D., Simes, R., Stockler, M., Tattersall, M., Wilcken, N., Henderson, I., Basser, R., Brunswick, C., Fossati, R., Liberati, A., et al (2001). Platinum containing reimens for metastatic breast cancer [protocol]. Cochrane Database of Systematic Reviews, Issue 4, 1-4.
  • Ghersi, D., Gebski, V., Keech, A. (2001). Scientific background and rationale for a randomised controlled trial. Medical Journal of Australia, 175(7), 386-386.
  • Ghersi, D., Simes, R., Stockler, M., Tattersall, M., Wilcken, N., Henderson, I., Basser, R., Brunswick, C., Fossati, R., Liberati, A., et al (2001). Single agent vs combination chemotherapy for metastatic breast cancer [protocol]. Cochrane Database of Systematic Reviews, Issue 4, 1-4.
  • Ghersi, D., Simes, R., Stockler, M., Tattersall, M., Wilcken, N., Henderson, I., Basser, R., Brunswick, C., Fossati, C., Liberati, A., et al (2001). Taxane containing regimens for metastatsic breast cancer [protocol]. Cochrane Database of Systematic Reviews, Issue 4, 1-4.
  • Ghersi, D., Simes, R., Stockler, M., Tattersall, M., Wilcken, N., Henderson, I., Basser, R., Brunswick, C., Fossati, R., Liberati, A., et al (2001). Two drug combinations vs combinations of 3 or more cytotoxic drugs for meastatic brest cancer [protocol]. Cochrane Database of Systematic Reviews, Issue 4, 1-4.

2000

  • Stockler, M., Wilcken, N., Ghersi, D., Simes, R. (2000). Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. Cancer Treatment Reviews, 26(3), 151-168.

To update your profile click here. For support on your academic profile contact .